C. Currie

First name
C.
Middle name
J.
Last name
Currie
Jones, B. I., Jenkins, C. A., Murphy, D. ., Orr, J. ., Yeoman, A. ., Hubbuck, E. R., … Currie, C. J. (2023). Predicting hepatic encephalopathy in patients with cirrhosis: A UK population-based study and validation of risk scores. Hepatol Commun, 7. http://doi.org/10.1097/hc9.0000000000000307
Heywood, B. R., Morgan, C. L., Berni, T. R., Summers, D. R., Jones, B. I., Jenkins-Jones, S. ., … Currie, C. J. (2023). Real-world evidence from the first online healthcare analytics platform-Livingstone. Validation of its descriptive epidemiology module. PLOS Digit Health, 2, e0000310. http://doi.org/10.1371/journal.pdig.0000310
Currie, C. J., Peters, J. R., Tynan, A. ., Evans, M. ., Heine, R. J., Bracco, O. L., … Poole, C. D. (2010). Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet. http://doi.org/10.1016/s0140-6736(09)61969-3
Morgan, C. L., Poole, C. D., Evans, M. ., Barnett, A. H., Jenkins-Jones, S. ., & Currie, C. J. (2012). What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes. J Clin Endocrinol Metab. http://doi.org/10.1210/jc.2012-3034
Morgan, C. L., Jenkins-Jones, S. ., Evans, M. ., Barnett, A. H., Poole, C. D., & Currie, C. J. (2012). Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs. Diabetes Obes Metab. http://doi.org/10.1111/j.1463-1326.2011.01552.x
Morgan, C. L., Jenkins-Jones, S. ., Currie, C. J., & Rees, D. A. (2012). Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. J Clin Endocrinol Metab. http://doi.org/10.1210/jc.2012-1690
Morgan, C. L., Owens, D. R., Aubonnet, P. ., Carr, E. S., Jenkins-Jones, S. ., Poole, C. D., & Currie, C. J. (2013). Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2013-004025
Holden, S. E., Jenkins-Jones, S. ., Poole, C. D., Morgan, C. L., Coghill, D. ., & Currie, C. J. (2013). The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010). Child Adolesc Psychiatry Ment Health. http://doi.org/10.1186/1753-2000-7-34
Poole, C. D., Halcox, J. P., Jenkins-Jones, S. ., Carr, E. S., Schifflers, M. G., Ray, K. K., & Currie, C. J. (2013). Omega-3 Fatty acids and mortality outcome in patients with and without type 2 diabetes after myocardial infarction: a retrospective, matched-cohort study. Clin Ther. http://doi.org/10.1016/j.clinthera.2012.11.008
Holden, S. H., Barnett, A. H., Peters, J. R., Jenkins-Jones, S. ., Poole, C. D., Morgan, C. L., & Currie, C. J. (2013). The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes Obes Metab. http://doi.org/10.1111/dom.12123